Mast Cell Activation Syndromes Presenting as Anaphylaxis - 03/04/15
Résumé |
Anaphylaxis results from severe systemic mast cell activation. In addition to IgE-mediated and physical triggers, it may occur with a clonal mast cell disease and in an idiopathic fashion without clear provoking factors. Disorders of mast cell activation are classified into primary (clonal), secondary, and idiopathic. Mast cell activation syndrome (MCAS) is a multisystem disorder characterized by objective documentation of elevated mast cell mediators during attacks and a favorable response to antimediator therapy. It should be considered in the differential diagnosis of patients presenting with recurrent anaphylaxis without a clear cause. This article discusses the diagnosis of MCAS.
Le texte complet de cet article est disponible en PDF.Keywords : Anaphylaxis, Mastocytosis, Mast cell activation syndrome, Mast cells, Tryptase
Plan
| Disclosure: Consultancy agreements with Novartis, Patara Pharma, and Blueprint Medicines. |
Vol 35 - N° 2
P. 277-285 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

